While the precise function of FCGBP in response to radiotherapy and/or chemotherapy remains incompletely understood, as these treatments induce DNA damage in cancer cells, FCGBP may contribute to tumor resistance against these DNA toxins by forming a molecular shield [30]. This evidence concerns the gene FCGBP and neoplasm.